Cargando…
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau
BACKGROUND: Children in Guinea-Bissau receive measles vaccine (MV) at 9 months of age, but studies have shown that an additional dose before 9 months of age might have beneficial nonspecific effects. Within a randomized trial designed to examine nonspecific effects of early MV receipt on mortality,...
Autores principales: | Do, Vu An, Biering-Sørensen, Sofie, Fisker, Ane Bærent, Balé, Carlito, Rasmussen, Stine Møller, Christensen, Lone Damkjær, Jensen, Kristoffer Jarlov, Martins, Cesário, Aaby, Peter, Benn, Christine Stabell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441109/ https://www.ncbi.nlm.nih.gov/pubmed/28077730 http://dx.doi.org/10.1093/infdis/jiw512 |
Ejemplares similares
-
The mortality effects of disregarding the strategy to save doses of measles vaccine: a cluster-randomised trial in Guinea-Bissau
por: Byberg, Stine, et al.
Publicado: (2021) -
Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau
por: Byberg, Stine, et al.
Publicado: (2017) -
Seasonal variation in child mortality in rural Guinea‐Bissau
por: Nielsen, Bibi Uhre, et al.
Publicado: (2017) -
Seasonal and sex-specific variations in haematological parameters in 4 to 5.5-month-old infants in Guinea-Bissau, West Africa
por: Bæk, Ole, et al.
Publicado: (2017) -
BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014)